Cargando…

Animal Models of Lassa Fever

Lassa virus (LASV), the causative agent of Lassa fever, is estimated to be responsible for up to 300,000 new infections and 5000 deaths each year across Western Africa. The most recent 2018 and 2019 Nigerian outbreaks featured alarmingly high fatality rates of up to 25.4%. In addition to the severit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sattler, Rachel A., Paessler, Slobodan, Ly, Hinh, Huang, Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157617/ https://www.ncbi.nlm.nih.gov/pubmed/32155851 http://dx.doi.org/10.3390/pathogens9030197

Ejemplares similares

Sequelae of Lassa Fever: Postviral Cerebellar Ataxia
por: Ezeomah, Chiomah, et al.
Publicado: (2019)

Lassa fever–induced sensorineural hearing loss: A neglected public health and social burden
por: Mateer, Elizabeth J., et al.
Publicado: (2018)

Lassa Fever: Viral Replication, Disease Pathogenesis, and Host Immune Modulations
por: Ly, Hinh
Publicado: (2020)

Pathogenicity and virulence mechanisms of Lassa virus and its animal modeling, diagnostic, prophylactic, and therapeutic developments
por: Murphy, Hannah L., et al.
Publicado: (2021)

Virulent infection of outbred Hartley guinea pigs with recombinant Pichinde virus as a surrogate small animal model for human Lassa fever
por: Lan, Shuiyun, et al.
Publicado: (2020)

CD4 T-cell depletion prevents Lassa fever associated hearing loss in the mouse model
por: Maruyama, Junki, et al.
Publicado: (2022)

Pichinde Virus Infection of Outbred Hartley Guinea Pigs as a Surrogate Animal Model for Human Lassa Fever: Histopathological and Immunohistochemical Analyses
por: Shieh, Wun-Ju, et al.
Publicado: (2020)

Lethal Infection of Lassa Virus Isolated from a Human Clinical Sample in Outbred Guinea Pigs without Adaptation
por: Maruyama, Junki, et al.
Publicado: (2019)

Lassa virus diversity and feasibility for universal prophylactic vaccine
por: Lukashevich, Igor S., et al.
Publicado: (2019)

Understanding Immune Responses to Lassa Virus Infection and to Its Candidate Vaccines
por: Murphy, Hannah, et al.
Publicado: (2022)

Lassa virus NP DEDDh 3’-5’ exoribonuclease activity is required for optimal viral RNA replication
por: Huang, Cheng, et al.
Publicado: (2023)

Lassa virus isolates from Mali and the Ivory Coast represent an emerging fifth lineage
por: Manning, John T., et al.
Publicado: (2015)

Pathogenesis of Lassa Fever
por: Yun, Nadezhda E., et al.
Publicado: (2012)

Epidemiological review of confirmed Lassa fever cases during 2016–2018, in Plateau State, North Central Nigeria
por: Gomerep, Simji, et al.
Publicado: (2022)

Differential Immune Responses to Hemorrhagic Fever-Causing Arenaviruses
por: Mantlo, Emily, et al.
Publicado: (2019)

Lassa fever — the road ahead
por: Garry, Robert F.
Publicado: (2022)

Effect of Strain Variations on Lassa Virus Z Protein-Mediated Human RIG-I Inhibition
por: Huang, Qinfeng, et al.
Publicado: (2020)

Lassa Fever 2016 Outbreak in Plateau State, Nigeria—The Changing Epidemiology and Clinical Presentation
por: Shehu, Nathan Y., et al.
Publicado: (2018)

Advanced Vaccine Candidates for Lassa Fever
por: Lukashevich, Igor S.
Publicado: (2012)

Vaccine platforms for the prevention of Lassa fever
por: Purushotham, Jyothi, et al.
Publicado: (2019)

Comparative Animal Models of Human Viral Infections
por: Ly, Hinh
Publicado: (2022)

On the Front Lines of Lassa Fever
por: Bausch, Daniel G., et al.
Publicado: (2004)

Cap binding and immune evasion revealed by Lassa nucleoprotein structure
por: Qi, Xiaoxuan, et al.
Publicado: (2010)

Lassa fever: another threat from West Africa
por: Brosh-Nissimov, Tal
Publicado: (2016)

High-Resolution Structure of the N-Terminal Endonuclease Domain of the Lassa Virus L Polymerase in Complex with Magnesium Ions
por: Wallat, Gregor D., et al.
Publicado: (2014)

Pathogenesis of lassa fever in cynomolgus macaques
por: Hensley, Lisa E, et al.
Publicado: (2011)

Lassa Fever, Nigeria, 2005–2008
por: Ehichioya, Deborah U., et al.
Publicado: (2010)

The COVID-19 Impact on the Trends in Yellow Fever and Lassa Fever Infections in Nigeria
por: Opara, Nnennaya U., et al.
Publicado: (2022)

Time to reconsider the role of ribavirin in Lassa fever
por: Salam, Alex Paddy, et al.
Publicado: (2021)

The niche of One Health approaches in Lassa fever surveillance and control
por: Arruda, Liã Bárbara, et al.
Publicado: (2021)

T Cell-Dependence of Lassa Fever Pathogenesis
por: Flatz, Lukas, et al.
Publicado: (2010)

Lassa Fever, Nigeria, 2003 and 2004
por: Omilabu, Sunday Aremu, et al.
Publicado: (2005)

Ribavirin for Lassa Fever Postexposure Prophylaxis
por: Hadi, Christiane M., et al.
Publicado: (2010)

Laboratory Diagnosis of Lassa Fever, Liberia
por: Panning, Marcus, et al.
Publicado: (2010)

Lassa fever and global health security
por: The Lancet Infectious Diseases
Publicado: (2018)

PROSPECTS OF LASSA FEVER CANDIDATE VACCINES
por: Isaac, Ademusire Babatunde, et al.
Publicado: (2022)

Imported lassa fever in Germany: molecular characterization of a new lassa virus strain.
por: Günther, S, et al.
Publicado: (2000)

Humoral and cellular immune responses to Lassa fever virus in Lassa fever survivors and their exposed contacts in Southern Nigeria
por: Ugwu, Chinedu, et al.
Publicado: (2022)

Immunosuppression by hemorrhagic fever-causing viruses
por: Meyer, Bjoern, et al.
Publicado: (2015)

Human Hemorrhagic Fever Causing Arenaviruses: Molecular Mechanisms Contributing to Virus Virulence and Disease Pathogenesis
por: Shao, Junjie, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6r4ta2qgui85h6ghpuqvchr97q